-
ABC7 | Dr.Eric P. Winer:Do a good job of managing advanced breast cancer patients
Since the 6th International Consensus Conference on Advanced Breast Cancer (ABC6), the field of advanced breast cancer treatment has changed a lot with the emergence of new therapeutic agents. At the 7th International Consensus Conference on Advanced Breast Cancer (ABC7), Oncology Frontier invited Dana-Farber Cancer Institute Dr.Eric P.Winer to share with us the changing treatment…
-
Dr.Hu Xichun &Hope S. Rugo: Future treatment strategies for advanced triple-negative breast cancer and HR+/ HER2-breast cancer from the perspective of ADC drug treatment progress
The International Consensus Conference on Advanced Breast Cancer (ABC) is the premier international conference in the academic field of advanced breast cancer, whose primary goal is to develop international consensus guidelines for the management of patients with advanced breast cancer. These guidelines are based on the latest evidence and can be used to guide treatment…
-
CDL (co-management of diabetes-liver diseases strategy,) Literature Monthly Review – November 2023, Issue 10
Introduction:Diabetes and liver diseases are common chronic conditions in China, and they interact in terms of pathogenesis, clinical manifestations, and therapeutic targets, often posing mutual risk factors. Co-management of these…
-
Impact of Treatment Adjustments on the Prognosis of “T+A” Therapy in Unresectable Hepatocellular Carcinoma
Editor’s Note: The combination of atezolizumab and bevacizumab (“T+A”) has emerged as the first-line standard treatment for unresectable hepatocellular carcinoma (uHCC) and is widely used in clinical practice. However, the…
-
Expert Insights | Dr. LechengYu: Is Mass Screening Necessary for HBV Infection in the General Population?
HBV infection is a global epidemic. According to the latest 2019 Global Burden of Disease (GBD) report[1], the global prevalence of chronic HBV infection in 2019 was approximately 4.1% (3.7%-4.5%),…
-
Striking Hard to Overcome the Final “Fortress” of Antiviral Treatment for Hepatitis C
The WHO has set the goal of “eliminating viral hepatitis by 2030,” with a 90% reduction in the new infection rate, a 65% reduction in mortality, a 90% diagnosis rate,…
-
Dr.JianWu: How to Prevent and Treat Overlooked “Hepatitis E”?
“Hepatology Digest”: First, could you talk about the current global and Chinese epidemiology and treatment of Hepatitis E? What are the main challenges in treatment? How has our understanding of Hepatitis…
-
Understanding and Managing Chronic Hepatitis B: The Importance of Detailed Assessment
By Shuquan Cheng Chief Physician, Department of Hepatology, Third People’s Hospital of Guilin Since the introduction of the first oral nucleos(t)ide analogs (NAs) lamivudine for the treatment of chronic hepatitis…
Connecting Medical Expertise through Media